Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipeline

(5:)

Sanofi - Treating Diabetes for More Than a Century

(12:50)

Sanofi and GSK see positive interim results for their Covid vaccine in trials

(2:31)

Sanofi and Regeneron introduces medication for COPD

(2:53)

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

(8:54)

Sanofi – R\u0026D Day

(4:24:45)

THE WORLD OF PHARMACY | EPISODE 18 | REV. DR MOSES MWANGI

(2:2:49)

Sanofi and GSK to join forces in vaccine collaboration to fight COVID-19

(3:36)

Sanofi – What is an EVolutive Facility?

(49)

Dock \u0026 Talk: Strategic Leadership – Kim Le Huy on Navigating Global Logistics and Business Success

(41:25)

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

(19:37)

Pharmaceutical giant Sanofi looks to sell consumer health unit, sparks political uproar

(5:28)

Sanofi's Internship and Co-op Program Experience

(3:40)

Sanofi India Demerger Analysis | Sanofi India Share Latest Market News | Sanofi India Share Analysis

(21:34)

Yellow Fever \u0026 Polio Vaccines before travelling to Africa/South America | Hindi

(5:26)

Sanofi’s CEO on How Company Culture Can Thrive in a Distributed, Hybrid World

(32:36)

Sanofi – Behind the Lens: Our Global Responsibility

(11:44)

Sanofi chief on new partnership with OpenAI for AI-driven drug development

(4:1econd)

Rejuvenating the Immune System to Extend Lifespan \u0026 Healthspan | Dr Alessio Lanna Interview

(45:17)

Sanofi CEO Paul Hudson on Q3 results: The modernization effort is starting to pay off

(6:27)

U.S. to pay Sanofi, GSK $2.1 bln for vaccines

(1:21)

Successful Partnership Between Sanofi and Regeneron

(10:27)

How SandboxAQ and Sanofi are transforming healthcare with AI | CNBC International

(2:10)

Sanofi – Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R\u0026D

(4:14)

Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma

(4:24)

Sanofi, GSK launch trial for COVID-19 vaccine

(1:20)

Sanofi sees vaccine trial completed in first quarter

(56)